IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mast Therapeutics Inc

CUSIP: 576314958 | 4 institutional holders

Quarters

Q3 2016Q2 2016Q4 2014Q2 2014Q1 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile